Stable nanovesicles for the delivery of microRNA in cancer treatment

Researchers at ICMAB present a study on new nanovesicles, known as quatsomes, which have been successfully engineered to encapsulate and deliver microRNAs for the treatment of tumors. These nanovesicles are produced by a simple GMP compliant process, an unavoidable requirement for the clinical use of new drug candidates. The study, published in Small, has been highlighted in the Women in Materials Science issue of Advanced Materials.